The Patent Finder

Cragmont Pharmaceuticals, LLC

Also on record
Records under this name other than patents Cragmont Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Cragmont Pharmaceuticals, LLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,933,3011,2,3,6-tetrahydropyrimidine-2-one compositions, articles and therapeutic methods for upper airway breathing disorders
Lapsed on the fee record
Ended Aug 23, 2017 · USPTO record
Lapsed on the fee recordEnded Aug 23, 2017USPTO record
US 6,919,348Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
Lapsed on the fee record
Ended Jul 19, 2017 · USPTO record
Lapsed on the fee recordEnded Jul 19, 2017USPTO record
US 6,743,8011,2,3,6-tetrahydropyrimidine-2-one compositions and therapeutic methods therewith for pain and inflammation
Lapsed on the fee record
Ended Jun 1, 2016 · USPTO record
Lapsed on the fee recordEnded Jun 1, 2016USPTO record
US 5,744,452.gamma.-L-glutamyl containing immunomodulator compounds and methods therewith
Term ended
Term ended no later than Apr 28, 2018 · Low confidence
Term endedTerm ended no later than Apr 28, 2018Low confidence
US 5,916,878.Gamma.-glutamyl and .beta.-aspartyl containing immunomodulator compounds and methods therewith
Term ended
Term ended no later than Jun 29, 2019 · Low confidence
Term endedTerm ended no later than Jun 29, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited